These results indicated that the intratracheal administration of PS-MPs induced pulmonary fibrosis in the rats, which may be related to the release of proinflammatory cytokines by PS-MP-activated macrophages and the activation of TGF-β1 and its downstream signals in the lungs. Here, TGFB1 is linked to pulmonary fibrosis.